DE602005021678D1 - Verfahren zur gewinnung von antikörpern - Google Patents

Verfahren zur gewinnung von antikörpern

Info

Publication number
DE602005021678D1
DE602005021678D1 DE602005021678T DE602005021678T DE602005021678D1 DE 602005021678 D1 DE602005021678 D1 DE 602005021678D1 DE 602005021678 T DE602005021678 T DE 602005021678T DE 602005021678 T DE602005021678 T DE 602005021678T DE 602005021678 D1 DE602005021678 D1 DE 602005021678D1
Authority
DE
Germany
Prior art keywords
relates
obtaining antibodies
yield
subjected
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005021678T
Other languages
English (en)
Inventor
Mukesh Sehdev
Mariangela Spitali
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma SA
Original Assignee
UCB Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33548568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602005021678(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by UCB Pharma SA filed Critical UCB Pharma SA
Publication of DE602005021678D1 publication Critical patent/DE602005021678D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
DE602005021678T 2004-11-19 2005-11-16 Verfahren zur gewinnung von antikörpern Active DE602005021678D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0425534.5A GB0425534D0 (en) 2004-11-19 2004-11-19 Process for obtaining antibodies
PCT/GB2005/004397 WO2006054063A1 (en) 2004-11-19 2005-11-16 Process for obtaining antibodies

Publications (1)

Publication Number Publication Date
DE602005021678D1 true DE602005021678D1 (de) 2010-07-15

Family

ID=33548568

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005021678T Active DE602005021678D1 (de) 2004-11-19 2005-11-16 Verfahren zur gewinnung von antikörpern

Country Status (11)

Country Link
US (1) US8969036B2 (de)
EP (1) EP1814912B2 (de)
JP (1) JP4843616B2 (de)
CN (1) CN101065402B (de)
AT (1) ATE469917T2 (de)
AU (1) AU2005305681B2 (de)
CA (1) CA2584226C (de)
DE (1) DE602005021678D1 (de)
ES (1) ES2346673T5 (de)
GB (1) GB0425534D0 (de)
WO (1) WO2006054063A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0425537D0 (en) * 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
HUE037633T2 (hu) 2007-07-09 2018-09-28 Genentech Inc Diszulfidkötés redukciójának megelõzése polipeptidek rekombináns elõállítása során
ES2499391T5 (es) * 2007-10-15 2021-12-22 Chugai Pharmaceutical Co Ltd Método para la producción de anticuerpos
HUE040306T2 (hu) 2009-09-24 2019-03-28 Ucb Biopharma Sprl Baktériumtörzs rekombináns fehérje expresszálására, amely tartalmaz proteázhiányos, de chaperonaktivitását megtartott DEGP-t és génkiütött TSP és PTR gént
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000591D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201001791D0 (en) 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
HUE035674T2 (en) 2011-07-13 2018-05-28 Ucb Biopharma Sprl Bacterial host strains expressing recombinant DSBC
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
CN102757496B (zh) * 2012-06-07 2014-06-18 山东泉港药业有限公司 一种抗vegf抗体片段的纯化制备方法
EA201791424A1 (ru) 2014-12-22 2017-10-31 Юсб Биофарма Спрл Получение белка
CA2969981C (en) 2014-12-22 2024-06-25 Ucb Biopharma Sprl A method for manufacturing a protein coupled to a peg molecule
GB201506869D0 (en) * 2015-04-22 2015-06-03 Ucb Biopharma Sprl Method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5328989B2 (de) * 1974-05-27 1978-08-17
WO1991001367A1 (en) * 1989-07-20 1991-02-07 Bioeng, Inc. Supercritical fluid disruption of and extraction from microbial cells
US7018809B1 (en) * 1991-09-19 2006-03-28 Genentech, Inc. Expression of functional antibody fragments
GB9215540D0 (en) * 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
US6455287B1 (en) * 1995-02-23 2002-09-24 Wyeth Mechanical disruption of bacterial cells for plasmid recovery
DE19513676A1 (de) 1995-04-11 1996-10-17 Behringwerke Ag Cytoplasmatische Expression von Antikörpern, Antikörperfragmenten und Antikörperfragmentfusionsmolekülen in E.coli
US6120985A (en) * 1997-10-31 2000-09-19 Bbi Bioseq, Inc. Pressure-enhanced extraction and purification
GB0319601D0 (en) 2003-08-20 2003-09-24 Sandoz Ag Production process

Also Published As

Publication number Publication date
GB0425534D0 (en) 2004-12-22
ATE469917T2 (de) 2010-06-15
EP1814912B1 (de) 2010-06-02
JP4843616B2 (ja) 2011-12-21
EP1814912B2 (de) 2017-10-25
CA2584226A1 (en) 2006-05-26
ES2346673T3 (es) 2010-10-19
CN101065402A (zh) 2007-10-31
WO2006054063A1 (en) 2006-05-26
US20080003644A1 (en) 2008-01-03
EP1814912A1 (de) 2007-08-08
ES2346673T5 (es) 2018-02-15
CN101065402B (zh) 2011-07-20
CA2584226C (en) 2015-09-15
JP2008520225A (ja) 2008-06-19
US8969036B2 (en) 2015-03-03
AU2005305681A1 (en) 2006-05-26
AU2005305681B2 (en) 2011-04-21

Similar Documents

Publication Publication Date Title
DE602005021678D1 (de) Verfahren zur gewinnung von antikörpern
EA200970263A1 (ru) Полностью человеческая высокопродуктивная система получения усовершенствованных антител и белков
ATE481483T1 (de) Verfahren zur herstellung eines rekombinanten polyklonalen proteins
WO2006041934A3 (en) Methods and compositions for improving recombinant protein production
NZ627668A (en) Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography
EA200700917A1 (ru) Способ рефолдинга рекомбинантных антител
DE602004025805D1 (de) Verfahren zur herstellung von antikörpern
WO2004065417A3 (en) Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
ATE468390T1 (de) System und verfahren zur produktion von antikörpern in der pflanzenzellkultur
TW200638944A (en) Recombinant enterovirus 71 neutralizing antibodies and use thereof
EA200700233A1 (ru) Новая последовательность для повышения экспрессии нуклеиновой кислоты
SG158739A1 (en) Aggrecanase molecules
DE602005026099D1 (de) Transformierte saccharomyces cerevisiae sowie verfahren zur massenproduktion des proteins lk8 damit
DE60214127D1 (de) Hybridomzelllinie g250 und deren verwendung zur herstellung monoklonaler antikörper
ATE373824T1 (de) Verfahren zur qualitativen und/oder quantitativen bestimmung von gattung, art, rasse und/oder geographischer herkunft biologischer materialien
DE50307968D1 (de) Antikörper zur isolierung und/oder identifizierung mesenchymaler stammzellen und verfahren zur isolierung und/oder identifizierung mesenchymaler stammzellen
DE602004029578D1 (de) Verfahren zur immuntherapie von tumoren
WO2013042917A3 (ko) 중공사막을 이용한 단백질의 효소 처리장치 및 이를 이용한 온-라인 프로테오믹스 방법
EA200702009A1 (ru) Усовершенствованный способ экспрессирующего клонирования в клетке-хозяине
EA200701105A1 (ru) Способ получения высоких уровней интерферона-бета
DE602004002388D1 (de) Verfahren zur herstellung von rekombinanten nukleinsäuremolekülen
WO2003064597A3 (en) Aggrecanase molecules
ATE381576T1 (de) Verfahren zur aufreinigung eines n-terminalen fragments des hepatozytenwachstumsfaktors
ATE384122T1 (de) Verfahren zur wiederverwendung fester träger zur kultivierung verankerungsabhängiger zellen
EA200700942A1 (ru) Способ определения качества клеточной культуры

Legal Events

Date Code Title Description
8363 Opposition against the patent